Eidos Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Eidos Therapeutics, Inc. Website Screenshot

http://www.eidostx.com

Eidos Therapeutics, Inc. Company Intro

Targeting TTR amyloidosis at its source. Transthyretin (TTR) amyloidosis is a family of rare, devastating diseases with serious unmet medical needs.

Industry

Healthcare

Eidos Therapeutics, Inc. Headquaters

101 Montgomery Street
San Francisco,94104
United States


Eidos Therapeutics, Inc. Share price

26 Jan 2021 01:33 GMT

$127.57

-0.87 (-0.68 %)


Eidos Therapeutics, Inc. Market cap

$4.751 B


WMC RANKING

2021

Eidos Therapeutics, Inc. # 127

Biotechnology

Latest Eidos Therapeutics, Inc. News

News 22 Jan 2021

US Transthyretin Amyloidosis Treatment Market 2020-2027 Analysis by Regional Development Status, Market Size, Market Dynamics, Applications

Alnylam Pharmaceuticals, Inc., Pfizer, Inc., Prothena Corporation Plc, GlaxoSmithKline Plc, Ionis Pharmaceuticals, Inc., Eidos Therapeutics, and SOM Innovation ...

News 22 Jan 2021

US Transthyretin Amyloidosis Treatment Market 2020-2027 Analysis by Regional Development Status, Market Size, Market Dynamics, Applications

Alnylam Pharmaceuticals, Inc., Pfizer, Inc., Prothena Corporation Plc, GlaxoSmithKline Plc, Ionis Pharmaceuticals, Inc., Eidos Therapeutics, and SOM Innovation ...

News 22 Jan 2021

US Transthyretin Amyloidosis Treatment Market 2020-2027 Analysis by Regional Development Status, Market Size, Market Dynamics, Applications

Alnylam Pharmaceuticals, Inc., Pfizer, Inc., Prothena Corporation Plc, GlaxoSmithKline Plc, Ionis Pharmaceuticals, Inc., Eidos Therapeutics, and SOM Innovation ...


WMC Market Score


WMC Market to Revenue Score


Eidos Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Eidos Therapeutics, Inc. USD $26,691 $64,642 $-37,835 $47,510B 127
Regeneron Pharmaceuticals, Inc. USD $9,243,500 $5,152,600 $3,156,000 $584,960B 1
Alexion Pharmaceuticals, Inc. USD $5,862,400 $2,588,400 $956,600 $352,840B 2
Vertex Pharmaceuticals Incorporated USD $5,991,128 $2,596,854 $2,690,691 $627,500B 3
ALK-Abello A/S USD $3,383,000 $1,831,000 $43,000 $271,200B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Eidos Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Eidos Therapeutics, Inc. Post vs Top 4 Industry Competitors




Eidos Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Eidos Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Eidos Therapeutics, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Eidos Therapeutics, Inc. 0.29 0 0 0 0 0 0
Regeneron Pharmaceuticals, Inc. 100 66.54 29.44 100 0 0 100
Alexion Pharmaceuticals, Inc. 63.42 16.37 100 60 0 0 90.05
Vertex Pharmaceuticals Incorporated 64.81 100 8.77 86 0 0 99.30
ALK-Abello A/S 36.60 0 0 0 0 0 0

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries